Aspirin in the treatment of acute myocardial infarction in elderly Medicare beneficiaries. Patterns of use and outcomes
- PMID: 7586250
- DOI: 10.1161/01.cir.92.10.2841
Aspirin in the treatment of acute myocardial infarction in elderly Medicare beneficiaries. Patterns of use and outcomes
Abstract
Background: Although aspirin is an effective, inexpensive, and safe treatment of acute myocardial infarction, the frequency of use of aspirin in actual medical practice is not known. Elderly patients, a group with low rates of utilization of effective therapies such as thrombolytic therapy, also may be at risk of not receiving aspirin for acute myocardial infarction. To address this issue, we sought to determine the current pattern of aspirin use and to assess its effectiveness in a large, population-based sample of elderly patients hospitalized with acute myocardial infarction.
Methods and results: As part of the Cooperative Cardiovascular Project Pilot, a Health Care Financing Administration initiative to improve quality of care for Medicare beneficiaries, we abstracted hospital medical records of Medicare beneficiaries who were hospitalized in Alabama, Connecticut, Iowa, or Wisconsin from June 1992 through February 1993. Among the 10,018 patients > or = 65 years old who had no absolute contraindications to aspirin, 6140 patients (61%) received aspirin within the first 2 days of hospitalization. Patients who were older, had more comorbidity, presented without chest pain, and had high-risk characteristics such as heart failure and shock were less likely to receive aspirin. The use of aspirin was significantly associated with a lower mortality (OR, 0.78; 95% CI, 0.70 to 0.89) after adjustment for potential confounders.
Conclusions: About one third of elderly patients with acute myocardial infarction who had no contraindications to aspirin therapy did not receive it within the first 2 days of hospitalization. The elderly patients with the highest risk of death were the least likely to receive aspirin. After adjustment for differences between the treatment groups, the use of aspirin was associated with 22% lower odds of 30-day mortality. The increased use of aspirin for patients with acute myocardial infarction is an excellent opportunity to improve the delivery of care to elderly patients.
Similar articles
-
Process and outcome of care for acute myocardial infarction among Medicare beneficiaries in Connecticut: a quality improvement demonstration project.Ann Intern Med. 1995 Jun 15;122(12):928-36. doi: 10.7326/0003-4819-122-12-199506150-00007. Ann Intern Med. 1995. PMID: 7755229
-
Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project.JAMA. 1995 May 17;273(19):1509-14. JAMA. 1995. PMID: 7739077
-
Aspirin for secondary prevention after acute myocardial infarction in the elderly: prescribed use and outcomes.Ann Intern Med. 1996 Feb 1;124(3):292-8. doi: 10.7326/0003-4819-124-3-199602010-00002. Ann Intern Med. 1996. PMID: 8554223
-
U.S. initiatives and approaches for outcomes and effectiveness research.Health Policy. 1991 Apr;17(3):209-25. doi: 10.1016/0168-8510(91)90125-h. Health Policy. 1991. PMID: 10111227 Review.
-
Is it safe to prescribe digoxin after acute myocardial infarction? Update on continued controversy.Am Heart J. 1995 Dec;130(6):1322-6. doi: 10.1016/0002-8703(95)90186-8. Am Heart J. 1995. PMID: 7484807 Review. No abstract available.
Cited by
-
Complexity in estimation of esomeprazole and its related impurities' stability in various stress conditions in low-dose aspirin and esomeprazole magnesium capsules.Sci Pharm. 2013 Apr-Jun;81(2):475-92. doi: 10.3797/scipharm.1212-13. Epub 2013 Feb 18. Sci Pharm. 2013. PMID: 23833714 Free PMC article.
-
Antiplatelet agents in the prevention of cardiovascular morbidity and mortality in older patients with vascular disease.Drugs Aging. 1999 Aug;15(2):91-101. doi: 10.2165/00002512-199915020-00003. Drugs Aging. 1999. PMID: 10495069 Review.
-
Early and pre-discharge aspirin administration among patients with acute myocardial infarction: current clinical practice and trends in the United States.J Thromb Thrombolysis. 2000 Apr;9(3):207-15. doi: 10.1023/a:1018706425864. J Thromb Thrombolysis. 2000. PMID: 10728018
-
The door-to-balloon alliance for quality: who joins national collaborative efforts and why?Jt Comm J Qual Patient Saf. 2009 Feb;35(2):93-9. doi: 10.1016/s1553-7250(09)35012-6. Jt Comm J Qual Patient Saf. 2009. PMID: 19241729 Free PMC article.
-
Opportunities for improving global cardiovascular quality of care and outcomes.J Am Heart Assoc. 2014 Oct 10;3(5):e001432. doi: 10.1161/JAHA.114.001432. J Am Heart Assoc. 2014. PMID: 25304855 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials